Abstract Details

Title Mesenchymal Stem Cells from Patients with Secondary Progressive Multiple Sclerosis Show Deficient Immunomodulatory Activity towards Homologous Immune Cells

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 388

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Cris S. Constantinescu, MD, PhD (Cooper Neurological Institute) PRESENTER	Dr. Constantinescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Constantinescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Constantinescu has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. The institution of Dr. Constantinescu has received research support from Nottingham University Hospital Charity.
	No disclosure on file
	No disclosure on file
Radu Tanasescu, MD (Clinical Neurology)	Dr. Tanasescu has received personal compensation for serving as an employee of Merck. Dr. Tanasescu has received personal compensation for serving as an employee of Novartis. Dr. Tanasescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tanasescu has received research support from UK MRC grant MR/T024402/1.
Bruno Gran, MD, PhD (Nottingham University Hospitals)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file